Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
Trial details
- Registry ID
- NCT06377930
- Phase
- Phase 2
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyNCT06377930 | RAPP | Phase 2 | Completed | 2025-09-26Actual |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderNCT07046494 | RAPP | Phase 2 | Active not recruiting | 2026-08-05Actual |
| A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresNCT07219407 | RAPP | Phase 2 | Recruiting | 2028-02-03Estimated |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1NCT07563881 | RAPP | Phase 3 | Recruiting | 2029-07Estimated |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresNCT07594119 | RAPP | Phase 3 | Recruiting | 2029-07Estimated |
NCT07046494 · Rapport Therapeutics Inc.
Estimated
Actual
250 participants (planned)
253 participants (actual)
Estimated
Actual
Sep 2026
5 Aug 2026
Recruiting
Active not recruiting
NCT07594119 · Rapport Therapeutics Inc.
Not yet recruiting
Recruiting
NCT07563881 · Rapport Therapeutics Inc.
Not yet recruiting
Recruiting
NCT07046494 · Rapport Therapeutics Inc.
224 participants (planned)
250 participants (planned)
Oct 2026
Sep 2026
NCT06377930 · Rapport Therapeutics Inc.
Estimated
Actual
28 Jul 2025
26 Sep 2025
Active not recruiting
Completed
NCT07219407 · Rapport Therapeutics Inc.
Not yet recruiting
Recruiting